











































In 1943, Bittner [1] demonstrated three cofactors in the
development of spontaneous mammary tumours in mice.
These were inherited susceptibility, hormonal influences,
and a transmissible influence in mother’s milk. This trans-
missible influence has since been shown to be a retro-
virus, now known as the mouse mammary tumor virus
(MMTV). This virus is oncogenic in the oestrogenic milieu
of female mice of strains with a genetic susceptibility to
mammary tumors [2]. Over the years, considerable indi-
rect and limited direct evidence has emerged that sug-
gests that an almost identical retrovirus to the MMTV, plus
additional cofactors, may influence human breast carcino-
genesis. This virus has become commonly known as
HHMMTV. In addition, evidence has recently emerged that
suggests additional viruses, such as the HPV and EBV,
may also initiate or promote breast carcinogenesis [3–7].
HHMMTV and MMTV
In 1971, Moore et al [2] demonstrated that human milk
from women who are at high risk for breast cancer con-
tains particles that are morphologically similar to the
MMTV. As shown in Fig. 1, these particles have a ‘mush-
room’ shape, with spikes on the viral envelope. Schlom et
al [8] showed that such particles had reverse transcrip-
tase activity, which is found in oncogenic retroviruses. Evi-
dence has since accumulated showing the presence of a
retrovirus that is homologous to MMTV in human breast
cancer tissues [9,10], in cultures of normal human breast
cells [11] and in cultures of human breast cancer cells
[12,13].
In 1971, Charney and Moore [14] showed that the serum
of humans with breast cancer decreased the virility of
MMTV, which suggested that antibodies to proteins of the
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virus may be present in humans. Antibodies that are reac-
tive with MMTV are present at much higher levels in serum
of humans with breast cancer than in serum of healthy
women [15]. Such antibody levels in women with breast
cancer vary from below 5% (in Chinese) to over 60% (in
East Africans) among different populations [15]. In addi-
tion, Stewart et al [16] collated data that suggest that the
geographic variation in human breast cancer parallels the
presence of the wild, but common house mouse, which
may have acted as an animal host of the MMTV.
Gene sequences that are congruent with those of MMTV
were detected and cloned in human breast cancer tissues
by Callahan et al in 1982 [17]. Such detection had been
difficult because of the presence of endogenous retroviral
sequences within the human genome that are homologous
with MMTV sequences. This problem has been largely
resolved by Wang et al [18] by using sequences that are
homologous to MMTV sequences, with low homology to
human endogenous retroviruses. MMTV env gene
sequences were found in 30–40% of breast cancer
tissues in women from various populations. The INT6
gene is a common integration site for MMTV in mouse
mammary tumours, and a human homologue with identical
INT6 peptide has been identified in human breast cancer
tissues [19].
Gene products of MMTV are present in concentrations
that are 1000–10,000 times greater in malignant than in
normal cells of mice [20]. It is not known whether this phe-
nomenon occurs with respect to HHMMTV, but it may
explain the difficulty experienced by Wang et al [18] in
detecting the HHMMTV in normal breast epithelial cells.
Endogenous HHMMTV has since been detected in normal
breast epithelial cells by Soble et al [21] and our group
(Rawlinson et al, unpublished data). The MMTV is highly
mammotrophic, but it can cause lymphomas in mice [20].
The HHMMTV also appears to be mammotrophic [18].
However, HHMMTV has recently been identified in both
breast and lymphoma tissues in several women with simul-
taneous diagnosis of breast cancer and non-Hodgkins
lymphoma [22]. Non-Hodgkins lymphoma occurs more
frequently in women with breast cancer than in the general
population [23]. In vitro studies of human breast cancer
cell lines [24] have shown that administration of oestrogen
followed by progesterone stimulates the expression of
human endogenous retroviruses in the genome.
The MMTV may be exogenous or endogenous [25]. The
exogenous MMTV particles are transmitted in maternal
milk but are not infectious for other mice [25]. The
endogenous noninfectious MMTV particles are transmitted
as part of the germline DNA [25]. Although both exoge-
nous and endogenous forms of the virus appear able to
induce mammary carcinogenesis independently in some
mouse strains, they may also combine and be carcino-
genic in the breast [25]. This phenomenon of recombina-
tion of exogenous and endogenous retroviruses, which
then induce cell proliferation, is known in other viruses
[26]. Therefore, it is possible that recombination of exoge-
nous and endogenous HHMMTV may occur, potentially
resulting in enhanced carcinogenesis.
Hormone and MMTV synergy
There is experimental evidence that glucocorticoids,
insulin, epidermal growth factors, oestrogens and prog-
estins synergize with MMTV in genetically susceptible
female mice to cause mammary cancers [20]. Male mice
are also exposed to exogenous and endogenous MMTV.
Although endogenous MMTV has been isolated in the
testes of male mice, these mice very rarely develop
mammary cancers [25]. One possibility is that circulating
oestrogen levels in male mice are not sufficiently high to
promote MMTV activity. However, an antigen that is
related to MMTV has been identified in approximately 90%
of human male mammary carcinomas [27].
Figure 1
Electron microscopy images of human and mouse mammary viruses
taken in 1971. (a) Electron microscope image (×180,000) of particles
from human milk. These particles are almost certainly the virions of the
HHMMTV. (b) Image (×180,000) of particles from mouse milk. These
particles are of the MMTV. The blurred edges of the particle  images
appear to be due to protein surface projections on the membrane of
the viruses. The morphological characteristics of the particles in both
the human and mouse milks appear to be almost identical and are
unique among all viruses. When these characteristics are considered
in conjunction with the 98% homology of the nucleotide sequences
between the HHMMTV and MMTV, it appears likely that these viruses
are variants of each other. Reprinted by permission from Nature [2]








































It is possible that MMTV is the initiator, and oestrogens and
other hormones are the promoters of some mammary
cancers in mouse models. However, the presence of MMTV
is not obligatory for all mouse mammary cancers [20].
Are there other viruses that cause breast
cancer in humans?
It has been shown [3] that HPV can immortalize normal
human mammary epithelial cells. This leads to the possibil-
ity that HPV may be associated with breast as well as cer-
vical carcinogenesis. In 1992, Lonardo et al [4]
demonstrated the presence of HPV type 16 in 29% of
breast tumors and metastatic lymph nodes using poly-
merase chain reaction techniques. Recently, HPV-16 has
been identified in both breast and cervical cancer tissues
in Norwegian women with concurrent breast and cervical
cancer [5]. In addition, HPV-33 has been identified in
breast tumors of 41% of Chinese and 11% of Japanese
women with breast cancer [6].
Bonnet et al [7] identified EBV in breast cancer tissues in
French women. This finding has provoked controversy,
because it has been suggested that the EBV identified by
Bonnet et al may have been present in infected lympho-
cytes in the breast [28]. EBV is ubiquitous in the popula-
tion and is present in many tissues. It is the initiator of
Burkitt’s lymphoma, and it is highly associated with some
cancers of epithelial origin such as nasopharangeal carci-
noma. Although speculative, it is possible that EBV may
enhance the action of HHMMTV, because it is known that
some viruses remain dormant unless activity is promoted
by other viruses [29,30].
Diets, oestrogens and breast cancer
Endogenous oestrogens are central to the aetiology of
breast cancer [31]; in the absence of oestrogens, breast
cancer does not occur. A recent prospective study of
Japanese women [32] indicated that levels of serum oestro-
gens are positively correlated with risk of breast cancer,
with a greater than threefold odds ratio in women with the
highest as compared with the lowest serum oestradiol.
In humans there are strong associations between dietary
pattern and level of circulating oestrogens, with energy-
rich diets correlated with high circulating oestrogens [33].
However, evidence from huge prospective studies [34]
has strongly suggested that there is no association
between dietary fats and breast cancer in humans. On the
other hand, the individuals studied were all from Europe
and North America, where the consumption of fats and
energy far exceed those of populations with low risk of
breast cancer. Well-conducted case–control and ecologi-
cal studies in populations with low risk of breast cancer,
such as Chinese, Japanese and Indonesian populations,
have shown that the risk of breast cancer is up to seven
times higher in women who consume the highest levels of
fats and energy in those populations [35–37]. These find-
ings parallel the consistent correlations between per
capita fat and energy consumption and breast cancer risk
between countries [38]. In addition, there is emerging evi-
dence from studies in humans [39] that different types of
dietary fat may have different influences on breast carcino-
genesis. N-6 polyunsaturated fats (as found in vegetable
margarines) may increase risk, and n-3 polyunsaturated
fats may reduce risk.
The associations between consumption of fats and energy
and mammary carcinogenesis in experimental rodents is
well established [40]. Experimental evidence in mice has
shown that diets that are high in n-6 polyunsaturated fats
(mainly sourced from corn) are associated with high
oestrogen receptor expression in mammary epithelial cells
and increased incidence of mammary tumours [41]. In
addition, such diets have been shown [42] to accelerate
the transcription of endogenous MMTV and to accelerate
carcinogenesis.
Epidemiology
The epidemiology of breast cancer is well established. The
most striking features of human breast cancer are the
100-fold greater incidence in females than in males, and
up to 10-fold greater incidence of breast cancer in
Western as compared with some Asian countries [31].
There is increased risk of breast cancer associated with
early age of menarche, late age of menopause, late age of
first full-term pregnancy, alcohol consumption and
increased postmenopausal weight [31]. It is also possible
that some forms of breast cancer originate during foetal
life [31]. With the exception of genetic influences, these
epidemiological features of breast cancer are probably all
associated directly or indirectly with oestrogen physiology,
which in turn may be associated with maternal diets during
gestation and lifetime diets [31]. The viral/diet/hormone
hypothesis is compatible with these epidemiological fea-
tures, particularly as endogenous retroviruses may remain
dormant for decades.
The case against a viral aetiology of breast
cancer
There is seemingly strong evidence against a infectious
cause of some types of breast cancer that is transmitted
by mothers milk. Nearly 30 years ago, Fraumeni and Miller
[43] summarized this evidence. Breast cancer rates are
low in countries where breast-feeding is prolonged, and
rates are increasing in countries where breast-feeding is
declining; breast cancer occurs equally in maternal and
paternal lines; and mother and daughter occurrences of
breast cancer are not associated with breast-feeding. In
addition, in a recent, large, case–control study of over
5685 US women with breast cancer [44], no evidence
was found that having been breast-fed increased breast
cancer risk in either premenopausal or postmenopausal
Available online http://breast-cancer-research.com/content/3/2/081women. An implication of this study is that human
mothers’ milk does not transmit an infectious agent.
However, it was also observed in that study that women
with breast cancer had a strong familial history of breast
cancer, an observation that is compatible with an endoge-
nous virus transmitted with germline cells, which may influ-
ence carcinogenesis in genetically susceptible individuals.
Conclusion
When considered as a whole and as shown on Fig. 2, this
evidence suggests that HHMMTV, and possibly other
transmissable viruses, in association with diet, steroid and
other hormones and genetic susceptibility, has a role in
human breast carcinogenesis. It is possible that HHMMTV
is transmitted as particles (virions) in mother’s milk and as
part of the endogenous viral genome in the germline.
Given the precedence of the association between MMTV
and murine cancer, it is also possible that the exogenous
HHMMTV (as virions in human maternal milk) may
combine with endogenous HHMMTV, which then has a
carcinogenic influence. Given the strong evidence against
a human milk-borne infectious agent, it may be that viral
human breast carcinogenesis only occurs if the endoge-
nous virus is present in the genome of the breast epithelial
cells, in addition to the exogenous virus that may be
present in breast milk. Diets with high intakes of energy
may lead to increased levels of oestrogen and other hor-
mones that may enhance expression of HHMMTV.
Many of these possibilities were suggested nearly 30
years ago [45]. At that time there was concern that, if
there was a human breast cancer virus that had the milk-
transmitted and inherited characteristics of the MMTV,
then primary prevention would probably be useless in the
face of immunological tolerance. However, if the above
hypotheses are shown to be true, then there is a possibil-
ity of primary prevention by dietary intervention aimed at a
reduction in serum oestrogens, vaccine immunization for
viral infections and the use of hormone-modifying agents
such as tamoxifen for women with HHMMTV [46].
All of these hypotheses are testable.
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